A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors.
Clinical trial NCT02925104 · COMPLETED
Trial details
- NCT number
- NCT02925104
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-14
- Primary completion
- 2018-05-16
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.